Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Alphapharm Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

(-) Cancellation by sponsor (813)
ARTG (832)
Prescription medicine registration (58)
Cancellation or suspension (52)
Australian public assessment report (AusPar) (3)
Designation or determination (3)
Prescription medicine decision summary (2)
Section 14, TGO91 consent (1)

Date

2025 (29)
2024 (7)
2023 (60)
2022 (149)
2021 (174)
2020 (48)
2019 (10)
2018 (33)
2017 (299)
2016 (4)

Search

Filters applied:

Cancellation by sponsor

Clear all

Sponsor content

813 result(s) found, displaying 711 to 720

MINAX XL metoprolol succinate 95 mg modified release tablet bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
MINAX XL metoprolol succinate 190 mg modified release tablet bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CANDESARTAN HCT ALPHAPHARM 32/25 candesartan cilexetil/hydrochlorothiazide 32 mg/25 mg tablets bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ADESAN HCT 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablet bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CANDESARTAN HCT ALPHAPHARM 32/25 candesartan cilexetil/hydrochlorothiazide 32 mg/25 mg tablets blister pack Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ADESAN HCT 32/25 candesartan cilexetil/hydrochlorothiazide 32 mg/25 mg tablets bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CANDESARTAN HCT ALPHAPHARM 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablets blister pack Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CANDESARTAN HCT ALPHAPHARM 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablets bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
LENOFIL fenofibrate 145 mg film-coated tablets bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
LENOFIL fenofibrate 48 mg film-coated tablets bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd

Pages

First page
Previous page
…
Page 68
Page 69
Page 70
Page 71
Current page 72
Page 73
Page 74
Page 75
Page 76
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.